You need to enable JavaScript to run this app.
FDA finalizes guidance for drugs and biologics containing nanomaterials
Regulatory News
Jeff Craven
Biologics
Biotechnology
North America
Pharmaceuticals
Preclinical study
Product Lifecycle
Research, Design and Development